(Q36635523)

15 August 2017

1 reference

title

Economic evaluations in the canadian common drug review (English)

1 reference

15 August 2017

Andreas Laupacis

1

1 reference

PubMed ID

17067199

15 August 2017

language of work or name

1 reference

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

24

1 reference

15 August 2017

11

1 reference

15 August 2017

1157-1162

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200624110-00011

15 August 2017

0 references

cites work

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200624110-00011

Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors

21 January 2018

1 reference

12 December 2020

Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).

1 reference

12 December 2020

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

1 reference

12 December 2020

Beyond fast track for drug approvals

1 reference

12 December 2020

NICE says that patients' age should affect treatment

1 reference

12 December 2020

A proposal for radical changes in the drug-approval process

1 reference

12 December 2020

Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study

1 reference

12 December 2020

Commissioning for rare diseases: view from the frontline

1 reference

12 December 2020

10.2165/00019053-200624110-00011

Identifiers

DOI

1 reference

PubMed ID

17067199

Dimensions Publication ID

15 August 2017

0 references

1 reference

PubMed ID

17067199